论文部分内容阅读
8月6日,溢多利披露拟以自有资金和金融机构借款向4名交易对方购买河南利华制药有限公司100%股权。2015年5月31日,利华制药股东的全部权益价值约为3.06亿元,合并报表净资产账面值约为2.08亿元,标的资产评估增值率为47.26%。经双方协商,此次交易利华制药100%股权作价为3.03亿元。公开信息显示,利华制药主要从事甾体激素类原料药的研发、生产与销售业务,根据
On August 6, Victorious Disclosures intends to acquire 100% equity interests in Henan Lihua Pharmaceutical Co., Ltd. from 4 counterparties with its own funds and financial institutions’ loans. As of May 31, 2015, the total equity value of Lihua Pharmaceutical’s shareholders was approximately 306 million yuan. The carrying value of the net assets of the consolidated financial statements was approximately 208 million yuan and the added value of the underlying assets assessment was 47.26%. After the two parties negotiated, the transaction Lihua Pharmaceutical 100% stake price of 303 million yuan. Public information shows that Lihua Pharmaceutical is mainly engaged in R & D, production and sales of steroid hormones, according to